<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-05T21:53:59Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/45358" metadataPrefix="ese">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/45358</identifier><datestamp>2021-09-21T08:57:17Z</datestamp><setSpec>com_10324_41462</setSpec><setSpec>com_10324_954</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_41463</setSpec></header><metadata><europeana:record xmlns:europeana="http://www.europeana.eu/schemas/ese/" xmlns:confman="org.dspace.core.ConfigurationManager" xmlns:doc="http://www.lyncode.com/xoai" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.europeana.eu/schemas/ese/ http://www.europeana.eu/schemas/ese/ESE-V3.4.xsd">
<dc:title>Clinical presentation of individuals with human T-Cell leukemia virus type-1 infection in spain</dc:title>
<dc:creator>Mendoza, Carmen de</dc:creator>
<dc:creator>Eiros Bouza, José María</dc:creator>
<dc:subject>Leucemia de células T adultas</dc:subject>
<dc:subject>HTLV-1</dc:subject>
<dc:subject>Epidemiología</dc:subject>
<dc:subject>32 Ciencias Médicas</dc:subject>
<dc:description>Producción Científica</dc:description>
<dc:description>Although only 8%–10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late diagnoses.&#xd;
Methods: &#xd;
A nationwide HTLV-1 register was created in Spain in 1989. A total of 351 infected persons had been reported by the end of 2017. We examined all new HTLV-1 diagnoses during the last decade and compared their clinical presentation.&#xd;
Results: &#xd;
A total of 247 individuals with HTLV-1 infection had been reported in Spain since year 2008. The incidence has remained stable with 20–25 new diagnoses yearly. Women represented 62%. Only 12% were native Spaniards, most of whom were foreigners from Latin America (72.5%). Up to 57 (23%) individuals presented clinically with HTLV-1-associated conditions, including subacute myelopathy (n = 24; 42.1%), T-cell lymphoma (n = 19; 33.3%), or Strongyloides stercoralis infestation (n = 8; 14%). Human T-cell leukemia virus type 1 diagnosis had been made either at blood banks (n = 109; 44%) or at clinics (n = 138; 56%). It is interesting to note that Spaniards and especially Africans were overrepresented among patients presenting with HTLV-1-associated illnesses, suggesting that misdiagnosis and late presentation are more frequent in these populations compared to Latin Americans.&#xd;
Conclusions: &#xd;
Given that 23% of new HTLV-1 diagnoses in Spain are symptomatic, underdiagnosis must be common. Although screening in blood banks mostly identifies asymptomatic Latin American carriers, a disproportionately high number of Spaniards and Africans are unveiled too late, that is, they already suffer from classic HTLV-1 illnesses.</dc:description>
<dc:date>2021-02-23T10:52:24Z</dc:date>
<dc:date>2021-02-23T10:52:24Z</dc:date>
<dc:date>2019</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>De Mendoza, Carmen, [et al.].Clinical presentation of individuals with human T-Cell leukemia virus type-1 infection in spain, Open Forum Infectious Diseases, 2019, vol. 6, n.2</dc:identifier>
<dc:identifier>2328-8957</dc:identifier>
<dc:identifier>http://uvadoc.uva.es/handle/10324/45358</dc:identifier>
<dc:identifier>10.1093/ofid/ofz036</dc:identifier>
<dc:identifier>2</dc:identifier>
<dc:identifier>Open Forum Infectious Diseases</dc:identifier>
<dc:identifier>6</dc:identifier>
<dc:identifier>2328-8957</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>https://academic.oup.com/ofid/article/6/2/ofz036/5290444</dc:relation>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>© Oxford University Press</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>Oxford University Press</dc:publisher>
<europeana:object>https://uvadoc.uva.es/bitstream/10324/45358/4/Clinical-presentation-individuals%20.pdf.jpg</europeana:object>
<europeana:provider>Hispana</europeana:provider>
<europeana:type>TEXT</europeana:type>
<europeana:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</europeana:rights>
<europeana:dataProvider>UVaDOC. Repositorio Documental de la Universidad de Valladolid</europeana:dataProvider>
<europeana:isShownAt>http://uvadoc.uva.es/handle/10324/45358</europeana:isShownAt>
</europeana:record></metadata></record></GetRecord></OAI-PMH>